目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. VIRAL ANTIGENS MARKET, BY TYPE (USD BILLION)
6.1. Viral Antigens Kits
6.2. Viral Antigens Reagents

7. VIRAL ANTIGENS MARKET, BY APPLICATION (USD BILLION)
7.1. Diagnostics
7.2. Drug Discovery
7.3. Vaccine Development

8. VIRAL ANTIGENS MARKET, BY VIRAL TARGET (USD BILLION)
8.1. Influenza
8.2. Hepatitis B
8.3. Hepatitis C
8.4. HIV
8.5. COVID-19

9. VIRAL ANTIGENS MARKET, BY REGIONAL (USD BILLION)
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. UK
9.2.3. France
9.2.4. Russia
9.2.5. Italy
9.2.6. Spain
9.2.7. Rest of Europe
9.3. APAC
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Malaysia
9.3.6. Thailand
9.3.7. Indonesia
9.3.8. Rest of APAC
9.4. South America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Argentina
9.4.4. Rest of South America
9.5. MEA
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of MEA

10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market share Analysis
10.4. Major Growth Strategy in the Viral Antigens Market
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Viral Antigens Market
10.7. Key developments and growth strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales and Operating Income
10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES
11.1. BioRad Laboratories
11.1.1. Financial Overview
11.1.2. Products Offered
11.1.3. Key Developments
11.1.4. SWOT Analysis
11.1.5. Key Strategies
11.2. Luminex Corporation
11.2.1. Financial Overview
11.2.2. Products Offered
11.2.3. Key Developments
11.2.4. SWOT Analysis
11.2.5. Key Strategies
11.3. DiaSorin
11.3.1. Financial Overview
11.3.2. Products Offered
11.3.3. Key Developments
11.3.4. SWOT Analysis
11.3.5. Key Strategies
11.4. Wako Pure Chemical Industries
11.4.1. Financial Overview
11.4.2. Products Offered
11.4.3. Key Developments
11.4.4. SWOT Analysis
11.4.5. Key Strategies
11.5. F. HoffmannLaRoche
11.5.1. Financial Overview
11.5.2. Products Offered
11.5.3. Key Developments
11.5.4. SWOT Analysis
11.5.5. Key Strategies
11.6. Youkey Pharma
11.6.1. Financial Overview
11.6.2. Products Offered
11.6.3. Key Developments
11.6.4. SWOT Analysis
11.6.5. Key Strategies
11.7. Bruker
11.7.1. Financial Overview
11.7.2. Products Offered
11.7.3. Key Developments
11.7.4. SWOT Analysis
11.7.5. Key Strategies
11.8. Vircell S.A.
11.8.1. Financial Overview
11.8.2. Products Offered
11.8.3. Key Developments
11.8.4. SWOT Analysis
11.8.5. Key Strategies
11.9. Abbott Laboratories
11.9.1. Financial Overview
11.9.2. Products Offered
11.9.3. Key Developments
11.9.4. SWOT Analysis
11.9.5. Key Strategies
11.10. Danaher
11.10.1. Financial Overview
11.10.2. Products Offered
11.10.3. Key Developments
11.10.4. SWOT Analysis
11.10.5. Key Strategies
11.11. QIAGEN
11.11.1. Financial Overview
11.11.2. Products Offered
11.11.3. Key Developments
11.11.4. SWOT Analysis
11.11.5. Key Strategies
11.12. Siemens Healthineers
11.12.1. Financial Overview
11.12.2. Products Offered
11.12.3. Key Developments
11.12.4. SWOT Analysis
11.12.5. Key Strategies
11.13. BioMérieux
11.13.1. Financial Overview
11.13.2. Products Offered
11.13.3. Key Developments
11.13.4. SWOT Analysis
11.13.5. Key Strategies
11.14. Agilent Technologies
11.14.1. Financial Overview
11.14.2. Products Offered
11.14.3. Key Developments
11.14.4. SWOT Analysis
11.14.5. Key Strategies
11.15. Thermo Fisher Scientific
11.15.1. Financial Overview
11.15.2. Products Offered
11.15.3. Key Developments
11.15.4. SWOT Analysis
11.15.5. Key Strategies

12. APPENDIX
12.1. References
12.2. Related Reports

LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 6. US VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 7. US VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 8. US VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 9. US VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 10. CANADA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 11. CANADA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 14. EUROPE VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 15. EUROPE VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 16. EUROPE VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 18. GERMANY VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 19. GERMANY VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 20. GERMANY VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 21. GERMANY VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. UK VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 23. UK VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 24. UK VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 25. UK VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 26. FRANCE VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 27. FRANCE VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 28. FRANCE VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 29. FRANCE VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 30. RUSSIA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 31. RUSSIA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 32. RUSSIA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 33. RUSSIA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 34. ITALY VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 35. ITALY VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 36. ITALY VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 37. ITALY VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 38. SPAIN VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 39. SPAIN VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 40. SPAIN VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 41. SPAIN VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. REST OF EUROPE VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 43. REST OF EUROPE VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 44. REST OF EUROPE VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 45. REST OF EUROPE VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 46. APAC VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 47. APAC VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 48. APAC VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 49. APAC VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 50. CHINA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 51. CHINA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 52. CHINA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 53. CHINA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 54. INDIA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 55. INDIA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 56. INDIA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 57. INDIA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 58. JAPAN VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 59. JAPAN VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 60. JAPAN VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 61. JAPAN VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. SOUTH KOREA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 63. SOUTH KOREA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 64. SOUTH KOREA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 65. SOUTH KOREA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 66. MALAYSIA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 67. MALAYSIA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 68. MALAYSIA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 69. MALAYSIA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 70. THAILAND VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 71. THAILAND VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 72. THAILAND VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 73. THAILAND VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 74. INDONESIA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 75. INDONESIA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 76. INDONESIA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 77. INDONESIA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 78. REST OF APAC VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 79. REST OF APAC VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 80. REST OF APAC VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 81. REST OF APAC VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. SOUTH AMERICA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 83. SOUTH AMERICA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 84. SOUTH AMERICA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 85. SOUTH AMERICA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 86. BRAZIL VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 87. BRAZIL VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 88. BRAZIL VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 89. BRAZIL VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 90. MEXICO VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 91. MEXICO VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 92. MEXICO VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 93. MEXICO VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 94. ARGENTINA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 95. ARGENTINA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 96. ARGENTINA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 97. ARGENTINA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF SOUTH AMERICA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF SOUTH AMERICA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF SOUTH AMERICA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF SOUTH AMERICA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. MEA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 103. MEA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 104. MEA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 105. MEA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 106. GCC COUNTRIES VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 107. GCC COUNTRIES VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 108. GCC COUNTRIES VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 109. GCC COUNTRIES VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 110. SOUTH AFRICA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 111. SOUTH AFRICA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 112. SOUTH AFRICA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 113. SOUTH AFRICA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 114. REST OF MEA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 115. REST OF MEA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 116. REST OF MEA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY VIRAL TARGET, 2019-2032 (USD BILLIONS)
TABLE 117. REST OF MEA VIRAL ANTIGENS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 118. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 119. ACQUISITION/PARTNERSHIP

LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA VIRAL ANTIGENS MARKET ANALYSIS
FIGURE 3. US VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 4. US VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 5. US VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 6. US VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 7. CANADA VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 8. CANADA VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 9. CANADA VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 10. CANADA VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 11. EUROPE VIRAL ANTIGENS MARKET ANALYSIS
FIGURE 12. GERMANY VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 13. GERMANY VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 14. GERMANY VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 15. GERMANY VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 16. UK VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 17. UK VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 18. UK VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 19. UK VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 20. FRANCE VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 21. FRANCE VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 22. FRANCE VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 23. FRANCE VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 24. RUSSIA VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 25. RUSSIA VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 26. RUSSIA VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 27. RUSSIA VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 28. ITALY VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 29. ITALY VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 30. ITALY VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 31. ITALY VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 32. SPAIN VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 33. SPAIN VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 34. SPAIN VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 35. SPAIN VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 36. REST OF EUROPE VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 37. REST OF EUROPE VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 38. REST OF EUROPE VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 39. REST OF EUROPE VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 40. APAC VIRAL ANTIGENS MARKET ANALYSIS
FIGURE 41. CHINA VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 42. CHINA VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 43. CHINA VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 44. CHINA VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 45. INDIA VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 46. INDIA VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 47. INDIA VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 48. INDIA VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 49. JAPAN VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 50. JAPAN VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 51. JAPAN VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 52. JAPAN VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 53. SOUTH KOREA VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 54. SOUTH KOREA VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 55. SOUTH KOREA VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 56. SOUTH KOREA VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 57. MALAYSIA VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 58. MALAYSIA VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 59. MALAYSIA VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 60. MALAYSIA VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 61. THAILAND VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 62. THAILAND VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 63. THAILAND VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 64. THAILAND VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 65. INDONESIA VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 66. INDONESIA VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 67. INDONESIA VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 68. INDONESIA VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 69. REST OF APAC VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 70. REST OF APAC VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 71. REST OF APAC VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 72. REST OF APAC VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 73. SOUTH AMERICA VIRAL ANTIGENS MARKET ANALYSIS
FIGURE 74. BRAZIL VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 75. BRAZIL VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 76. BRAZIL VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 77. BRAZIL VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 78. MEXICO VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 79. MEXICO VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 80. MEXICO VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 81. MEXICO VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 82. ARGENTINA VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 83. ARGENTINA VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 84. ARGENTINA VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 85. ARGENTINA VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 86. REST OF SOUTH AMERICA VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 87. REST OF SOUTH AMERICA VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 88. REST OF SOUTH AMERICA VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 89. REST OF SOUTH AMERICA VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 90. MEA VIRAL ANTIGENS MARKET ANALYSIS
FIGURE 91. GCC COUNTRIES VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 92. GCC COUNTRIES VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 93. GCC COUNTRIES VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 94. GCC COUNTRIES VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 95. SOUTH AFRICA VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 96. SOUTH AFRICA VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 97. SOUTH AFRICA VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 98. SOUTH AFRICA VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 99. REST OF MEA VIRAL ANTIGENS MARKET ANALYSIS BY TYPE
FIGURE 100. REST OF MEA VIRAL ANTIGENS MARKET ANALYSIS BY APPLICATION
FIGURE 101. REST OF MEA VIRAL ANTIGENS MARKET ANALYSIS BY VIRAL TARGET
FIGURE 102. REST OF MEA VIRAL ANTIGENS MARKET ANALYSIS BY REGIONAL
FIGURE 103. KEY BUYING CRITERIA OF VIRAL ANTIGENS MARKET
FIGURE 104. RESEARCH PROCESS OF MRFR
FIGURE 105. DRO ANALYSIS OF VIRAL ANTIGENS MARKET
FIGURE 106. DRIVERS IMPACT ANALYSIS: VIRAL ANTIGENS MARKET
FIGURE 107. RESTRAINTS IMPACT ANALYSIS: VIRAL ANTIGENS MARKET
FIGURE 108. SUPPLY / VALUE CHAIN: VIRAL ANTIGENS MARKET
FIGURE 109. VIRAL ANTIGENS MARKET, BY TYPE, 2024 (% SHARE)
FIGURE 110. VIRAL ANTIGENS MARKET, BY TYPE, 2019 TO 2032 (USD Billions)
FIGURE 111. VIRAL ANTIGENS MARKET, BY APPLICATION, 2024 (% SHARE)
FIGURE 112. VIRAL ANTIGENS MARKET, BY APPLICATION, 2019 TO 2032 (USD Billions)
FIGURE 113. VIRAL ANTIGENS MARKET, BY VIRAL TARGET, 2024 (% SHARE)
FIGURE 114. VIRAL ANTIGENS MARKET, BY VIRAL TARGET, 2019 TO 2032 (USD Billions)
FIGURE 115. VIRAL ANTIGENS MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 116. VIRAL ANTIGENS MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 117. BENCHMARKING OF MAJOR COMPETITORS